[1]许 贇,沈 强,王 能,等.微波消融治疗＞70岁早期肝细胞肝癌患者效果分析[J].介入放射学杂志,2016,(04):332-336.
　XU Yun,SHEN Qiang,WANG Neng,et al.Effect analysis of microwave ablation therapy for early hepatocellular carcinoma in patients over 70 years old[J].journal interventional radiology,2016,(04):332-336.
点击复制

微波消融治疗＞70岁早期肝细胞肝癌患者效果分析 ()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2016年04期
页码:
332-336
栏目:
非血管介入
出版日期:
2016-04-25

文章信息/Info

Title:
Effect analysis of microwave ablation therapy for early hepatocellular carcinoma in patients over 70 years old
作者:
许 贇;  沈 强;  王 能;  刘 沛;  盛月红;  许芸芸;  钱国军
Author(s):
XU Yun;  SHEN Qiang;  WANG Neng;  LIU Pei;  SHENG Yue- hong;  XU Yun- yun;  QIAN Guo- jun
Department of Minimally Invasive Therapy， Oriental Hepatobiliary Surgery Hospital， Second Military Medical University， Shanghai 200438， China

关键词:
【关键词】 肝细胞肝癌;  微波消融;  老年患者;  预后
文献标志码:
A
摘要:
【摘要】 目的 评估微波消融（MWA）治疗＞70岁早期肝细胞肝癌（HCC）患者的效果，分析预后相关因素。方法 2009年1月至2011年1月，第二军医大学东方肝胆外科医院收治的67例老年早期HCC患者接受了超声引导下经皮MWA治疗。结果 肿瘤完全消融率为97.3%，1、3、5 年总生存率分别为92.5%、73.0%、50.1%；1、3、5年无瘤生存率分别为76.1%、47.8%、34.3%。结论 MWA是治疗老年早期HCC患者安全有效的方式。丙型肝炎病毒感染和肿瘤直径≥3 cm是影响无瘤生存率的独立危险因素，肿瘤直径≥3 cm是影响总生存率的独立危险因素。

参考文献/References:

［1］ 叶胜龙， 秦叔逵， 吴孟超， 等． 原发性肝癌规范化诊治的专家共识［J］． 中国消化内镜， 2009， 25： 40- 51．
［2］ Lee SH, Choi HC, Jeong SH, et al. Hepatocellular carcinoma in older adults: clinical features, treatments, and survival［J］. J Am Geriatr Soc, 2011, 59: 241- 250.
［3］ Hiraoka A, Michitaka K, Horiike N, et al. Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients［J］. J Gastroenterol Hepatol, 2010, 25: 403- 407.
［4］ Peng ZW, Liu FR, Ye S, et al. Radiofrequency ablation versus open hepatic resection for elderly patients （> 65 years） with very early or early hepatocellular carcinoma［J］. Cancer, 2013, 119: 3812- 3820.
［5］ Zhang F, Wu G, Sun H, et al. Radiofrequency ablation of hepatocellular carcinoma in elderly patients fitting the Milan criteria： a single centre with 13 years experience［J］. Int J Hyper- thermia, 2014, 30: 471- 479.
［6］ Qian GJ, Wang N, Shen Q, et al. Efficacy of microwave versus radiofrequency ablation for treatment of small hepatocellular carcinoma: experimental and clinical studies［J］. Eur Radiol, 2012, 22: 1983- 1990.
［7］ Abdelaziz A, Elbaz T, Shousha HI, et al. Efficacy and survival analysis of percutaneous radiofrequency versus microwave ablation for hepatocellular carcinoma: an Egyptian multidisciplinary clinic experience［J］. Surg Endosc, 2014, 28: 3429- 3434.
［8］ 李晓峰， 钱国军， 张 磊， 等． 微波高功率条件下消融原发性肝癌的初步研究［J］． 介入放射学杂志， 2011， 20： 974- 978．
［9］ Bruix J, Sherman M. Management of hepatocellular carcinoma： an update［J］. Hepatology, 2011, 53: 1020- 1022.
［10］ Poon RT, Fan ST, Lo CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years［J］. Ann Surg, 2001, 234: 63- 70.
［11］ Fang Y, Chen W, Liang X, et al. Comparison of long- term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma［J］. J Gastroenterol Hepatol, 2014, 29: 193- 200.
［12］ Shi J, Sun Q, Wang Y, et al. Comparison of microwave ablation and surgical resection for treatment of hepatocellular carcinomas conforming to Milan criteria［J］. J Gastroenterol Hepatol, 2014, 29: 1500- 1507.
［13］ Groeschl RT, Pilgrim CH, Hanna EM, et al. Microwave ablation for hepatic malignancies: a multiinstitutional analysis［J］. Ann Surg, 2014, 259: 1195- 1200.
［14］ Liang P, Wang Y, Yu X, et al. Malignant liver tumors: treatment with percutaneous microwave ablation- complications among cohort of 1136 patients［J］. Radiology, 2009, 251: 933- 940.
［15］ 沈 强， 王 能， 盛月红， 等． 高功率微波消融治疗近大血管肝细胞癌33例［J］． 介入放射学杂志， 2012， 21： 391- 394．
［16］ Mirici- Cappa F, Gramenzi A, Santi V, et al. Treatments for hepato- cellular carcinoma in elderly patients are as effective as in younger patients: a 20- year multicentre experience［J］. Gut, 2010, 59: 387- 396.
［17］ Kao WY, Chiou YY, Hung HH, et al. Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy［J］. J Clin Gastroenterol, 2012, 46: 62- 70.
［18］ Choi GH, Kim DH, Kang CM, et al. Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma［J］. Ann Surg Oncol, 2008, 15： 618- 629.
［19］ Franssen B, Alshebeeb K, Tabrizian P, et al. Differences in surgical outcomes between hepatitis B- and hepatitis C- related hepatocellular carcinoma: a retrospective analysis of a single North American center［J］. Ann Surg, 2014, 260: 650- 656.
［20］ Santambrogio R, Costa M, Barabino M, et al. Recurrent hepato- cellular carcinoma successfully treated with laparoscopic thermal ablation［J］. Surg Endosc, 2012, 26： 1108- 1115.
［21］ Lee DH, Lee JM, Lee JY, et al. Radiofrequency ablation of hepatocellular carcinoma as first- line treatment: long- term results and prognostic factors in 162 patients with cirrhosis［J］. Radiology, 2014, 270: 900- 909.
［22］ Okusaka T, Okada S, Ueno H, et al. Satellite lesions in patients with small hepatocellular carcinoma with reference to clinico- pathologic features［J］. Cancer, 2002, 95: 1931- 1937.
［23］ McHugh PP, Gilbert J, Vera S, et al. Alpha- fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma［J］. HPB（Oxford）, 2010, 12: 56- 61.

相似文献/References:

[1]李晓峰,钱国军,张 磊,等. 微波高功率条件下消融原发性肝癌的初步研究[J].介入放射学杂志,2011,(12):974.
　LI Xiao-feng,QIAN Guo-jun,ZHANG Lei,et al.Microwave ablation with high output power for the treatment of hepatocellular carcinoma: a preliminary study[J].journal interventional radiology,2011,(04):974.
[2]陈奇峰,贾振宇,杨正强,等.肝动脉化疗栓塞联合微波消融与单独肝动脉化疗栓塞治疗大肝癌疗效meta分析[J].介入放射学杂志,2017,(03):225.
　CHEN Qifeng,JIA Zhenyu,YANG Zhengqiang,et al.TACE combined with MWA versus simple TACE for the treatment of large hepatic cancers： a meta- analysis of curative effect[J].journal interventional radiology,2017,(04):225.
[3]杨国威,张 巍,钱 晟,等.热损伤对肝细胞肝癌细胞增殖及侵袭转移特性影响的实验研究 [J].介入放射学杂志,2017,(05):436.
　YANG Guowei,ZHANG Wei,QIAN Sheng,et al.The effect of thermal damage on the cell proliferation and invasive metastasis of HCC： an experimental study in vitro[J].journal interventional radiology,2017,(04):436.
[4]李 鑫,梁 萍,于晓玲,等.经皮微波消融肾细胞癌疗效的超声造影评价[J].介入放射学杂志,2014,(08):688.
　LI Xin,LIANG Ping,YU Xiao ling,et al.Percutaneous microwave ablation for renal cell carcinoma： evaluation of therapeutic effect with contrast enhanced ultrasound[J].journal interventional radiology,2014,(04):688.
[5]杨柏帅,施裕新,袁 敏,等.TACE治疗既往有肝功能衰竭史肝癌患者七例[J].介入放射学杂志,2014,(09):805.
　YANG Bo shuai,SHI Yu xin,YUAN Min,et al.TACE treatment for patients with inoperable hepatocellular carcinoma and hepatic failure history： initial experience in seven cases[J].journal interventional radiology,2014,(04):805.
[6]王 会,胡继红,赵 卫. 骨肿瘤的消融治疗[J].介入放射学杂志,2012,(10):879.
　WANG Hui,HU Ji- hong,ZHAO Wei.. Recent advances in ablation therapy of bone neoplasm[J].journal interventional radiology,2012,(04):879.
[7]经 翔,丁建民,王彦冬,等. 射频消融和微波消融治疗肝癌的比较[J].介入放射学杂志,2014,(04):306.
　JING Xiang,DING Jian? min,WANG Yan? dong,et al. Ultrasound-guided percutaneous radiofrequency ablation and microwave ablation for the treatment of hepatocellular carcinoma： a comparison study[J].journal interventional radiology,2014,(04):306.
[8]邢桃红,牛焕章,周媛媛,等. TACE联合索拉非尼治疗23例中晚期肝细胞肝癌的护理[J].介入放射学杂志,2014,(05):449.
　XING Tao- hong,NIU Huan- zhang,ZHOU Yuan- yuan,et al. Nursing for patients with advanced hepatocellular carcinoma receiving transcatheter arterial chemoembolization combined with sorafenib： initial experience in 23 cases[J].journal interventional radiology,2014,(04):449.
[9]阿布都外力·吾布力卡斯穆,迪里木拉提·巴吾冬,任伟新. 巴塞罗那肝癌B期患者TACE治疗的预后及生存分析[J].介入放射学杂志,2014,(05):435.
　ABUDUWAILI Obulikasimu,DILMURAT Bawudun,REN Wei- xin.. Transcatheter arterial chemoembolization for the treatment of Barcelona stage B hepatocellular carcinoma： analysis of the prognosis and survival[J].journal interventional radiology,2014,(04):435.
[10]万豪光,许 伟,徐 浩,等. 经导管化疗栓塞联合经皮微波消融治疗中晚期肝癌64例的预后分析[J].介入放射学杂志,2014,(06):477.
　WAN Hao- guang,XU Wei,XU Hao,et al. Transcatheter arterial chemoembolization combined with percutaneous microwave ablation for the treatment of intermediate- advanced hepatocellular carcinoma： analysis of prognostic factors in 64 cases[J].journal interventional radiology,2014,(04):477.
[11]徐 圣,张学军,石宝琪,等.微波消融联合经导管动脉化疗栓塞术治疗肝细胞癌生存预测[J].介入放射学杂志,2020,29(05):508.
　XU Sheng,ZHANG Xuejun,SHI Baoqi,et al.The survival prediction for HCC patients receiving microwave ablation combined with TACE[J].journal interventional radiology,2020,29(04):508.

备注/Memo

备注/Memo:
（收稿日期：２０１5-０9-15）
（本文编辑：边 佶）
更新日期/Last Update: 2016-04-21